Class Action Lawsuit Announced Against Semler Scientific, Inc.

Class Action Lawsuit Announced Against Semler Scientific, Inc. — Key Dates for Investors

Investor Alert: Semler Scientific, Inc. Class Action Lawsuit

On September 18, 2025, Pomerantz Law Firm announced a class action lawsuit against Semler Scientific, Inc. (NASDAQ: SMLR), alerting investors who have encountered losses due to their investment to take note of the upcoming deadlines. For those interested in becoming involved, they are encouraged to reach out to Danielle Peyton via email or phone.

Overview of Allegations

The lawsuit centers around allegations of securities fraud or other illegal business practices committed by Semler and some of its high-ranking officials. The investigation is aimed at deciphering whether the company misled investors regarding its business operations, thus resulting in financial losses for those who invested during the specified period.

Important Deadlines for Investors

Investors who purchased Semler’s stocks from the start of the class period until October 28, 2025, will have a window of opportunity to apply to be the Lead Plaintiff in the case. Should anyone have questions regarding their eligibility, they can review the complaint available at Pomerantz's website.

Background of Semler Scientific, Inc.

Semler Scientific is recognized for providing innovative medical solutions, particularly with its QuantaFlo device—which is employed to assess peripheral artery disease. However, recent disclosures have raised serious concerns. In its annual report filed on February 28, 2025, Semler hinted at troubling developments, stating there exists a risk that the U.S. Department of Justice (DOJ) may instigate civil action against them following a long-standing investigation related to claims for reimbursement associated with their medical device.

In July 2017, the DOJ served Semler with a civil investigative demand concerning their marketing claims. Reports indicated that as of February 2025, Semler was involved in settlement discussions with the DOJ but reached no agreement. The repercussions of this situation were evident as Semler’s shares witnessed a significant drop from $38.89 to $34.86 after the news broke.

Subsequent Developments

Fast forward to April 15, 2025, and the company's predicament escalated as it announced a preliminary agreement with the DOJ to resolve claims by paying $29.75 million. The market did not respond favorably to this news, seeing an additional decline in stock price. The turbulent circumstances surrounding Semler's business dealings set the stage for the class action, now offering a crucial opportunity for affected investors to seek reparations.

The Purpose of the Class Action

Class action suits are designed to hold companies accountable for misconduct. In this instance, interested parties can band together to file a consolidated complaint against Semler, increasing their chances of effective legal recourse. Pomerantz LLP, a leading law firm in the realm of securities law, aims to advocate for the rights of investors, navigating through the intricacies of corporate misconduct and fraud on their behalf.

How to Get Involved

Investors who feel they have been impacted by Semler's operations can reach out to Pomerantz LLP for a consultation. Contact details for Danielle Peyton have been provided, urging people to include their contact information, share ownership details, and explore their options clearly.

This class action case serves as a reminder of the critical importance of corporate transparency and accountability, and the role of law firms in protecting investor interests effectively. Keep abreast of the updates, and take action before deadlines lapse, which are vital to your interests as an investor.

For more information, visit Pomerantz Law Firm’s website.